A novel technique to optimize facility locations of new nephrology services for remote areas.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3358989)

Published in Clin J Am Soc Nephrol on August 04, 2011

Authors

Bharati Ayyalasomayajula1, Natasha Wiebe, Brenda R Hemmelgarn, Aminu Bello, Braden Manns, Scott Klarenbach, Marcello Tonelli

Author Affiliations

1: Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Articles cited by this

Spatial accessibility of primary care: concepts, methods and challenges. Int J Health Geogr (2004) 6.38

Overview of the Alberta Kidney Disease Network. BMC Nephrol (2009) 2.58

Are rural residents less likely to obtain recommended preventive healthcare services? Am J Prev Med (2001) 2.45

Measuring progress in Healthy People 2010. Healthy People 2010 Stat Notes (2004) 2.04

Quality of care and mortality are worse in chronic kidney disease patients living in remote areas. Kidney Int (2010) 1.89

Association between residence location and likelihood of kidney transplantation in Aboriginal patients treated with dialysis in Canada. Kidney Int (2006) 1.67

Impact of geographic proximity to cardiac revascularization services on service utilization. Med Care (2000) 1.66

Regional effects of satellite haemodialysis units on renal replacement therapy in non-urban Ontario, Canada. Nephrol Dial Transplant (2007) 1.58

Association between proximity to the attending nephrologist and mortality among patients receiving hemodialysis. CMAJ (2007) 1.53

Do rural elders have limited access to Medicare hospice services? J Am Geriatr Soc (2004) 1.44

The use of health care services by people with diabetes in rural areas. J Rural Health (1998) 1.36

Remoteness of residence and survival from cancer in New South Wales. Med J Aust (2004) 1.33

The use of geographical information systems in examining variations in sociodemographic profiles of dental practice catchments: a case study of a Swansea practice. Prim Dent Care (2002) 1.14

The impacts of distance to hospital on families with a child with a chronic condition. Soc Sci Med (2001) 1.08

Rural/urban differences in health care utilization and place of death for persons with respiratory illness in the last year of life. Rural Remote Health (2010) 1.06

Determining geographic areas and populations with timely access to cardiac catheterization facilities for acute myocardial infarction care in Alberta, Canada. Int J Health Geogr (2007) 1.04

Integrating multi-criteria techniques with geographical information systems in waste facility location to enhance public participation. Waste Manag Res (2006) 1.03

Access and utilization of health services by British Columbia's rural Aboriginal population. Int J Health Care Qual Assur Inc Leadersh Health Serv (2005) 0.99

Rural inequalities in cancer care and outcome. Med J Aust (2005) 0.96

Rural health research in Canada: at the crossroads. Aust J Rural Health (2000) 0.93

Living in a rural area with advanced chronic respiratory illness: a qualitative study. Prim Care Respir J (2011) 0.92

Analyzing location-based accessibility to dental services: an Ohio case study. J Public Health Dent (2007) 0.91

The geography of diabetes in London, Canada: the need for local level policy for prevention and management. Int J Environ Res Public Health (2010) 0.86

Accessibility and quality of care received in emergency departments by Aboriginal and Torres Strait Islander people. Aust Health Rev (2008) 0.85

Rural beneficiaries with chronic conditions: does prevalence pose a risk to Medicare managed care? Manag Care Q (2000) 0.80

Factors influencing the speed of cancer diagnosis in rural Western Australia: a General Practice perspective. BMC Fam Pract (2007) 0.79

A pilot study of spatial patterns in referrals to a multicentre cancer genetics service. Community Genet (2005) 0.78

Articles by these authors

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Relation between kidney function, proteinuria, and adverse outcomes. JAMA (2010) 8.26

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int (2011) 6.21

Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol (2006) 6.21

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet (2012) 5.65

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47

Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31

The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension (2011) 5.14

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10

Cardiovascular disease in kidney donors: matched cohort study. BMJ (2012) 5.00

Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ (2013) 4.90

Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med (2004) 4.72

Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ (2011) 4.68

A systematic evaluation of the quality of meta-analyses in the critical care literature. Crit Care (2005) 4.51

Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med (2009) 4.35

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis (2010) 4.28

Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet (2012) 4.25

Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90

When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int (2009) 3.70

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56

Recommendations on screening for type 2 diabetes in adults. CMAJ (2012) 3.51

Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med (2011) 3.49

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet (2013) 3.44

Oral phosphate binders in patients with kidney failure. N Engl J Med (2010) 3.42

Recommendations on screening for cervical cancer. CMAJ (2013) 3.32

Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. Arch Intern Med (2012) 3.26

Early recognition and prevention of chronic kidney disease. Lancet (2010) 3.19

Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med (2011) 3.13

Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation (2005) 3.10

Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis (2002) 3.06

Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int (2013) 3.05

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int (2005) 3.03

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97

Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet (2010) 2.95

Oral estrogen therapy in postmenopausal women is associated with loss of kidney function. Kidney Int (2008) 2.88

Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol (2006) 2.84

Intensive care unit bed availability and outcomes for hospitalized patients with sudden clinical deterioration. Arch Intern Med (2012) 2.75

Validation of a case definition to define hypertension using administrative data. Hypertension (2009) 2.74

Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin. CMAJ (2009) 2.70

Physician awareness of drug cost: a systematic review. PLoS Med (2007) 2.63

Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA (2010) 2.61

Overview of the Alberta Kidney Disease Network. BMC Nephrol (2009) 2.58

Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int (2008) 2.56

Guidelines for the management of chronic kidney disease. CMAJ (2008) 2.54

Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med (2011) 2.48

A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis. Arch Pediatr Adolesc Med (2003) 2.47

Rates of treated and untreated kidney failure in older vs younger adults. JAMA (2012) 2.43

The direct and indirect economic costs incurred by living kidney donors-a systematic review. Nephrol Dial Transplant (2006) 2.41

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ (2011) 2.40

Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA (2012) 2.38

Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2007) 2.38

Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int (2004) 2.37

Association between LDL-C and risk of myocardial infarction in CKD. J Am Soc Nephrol (2013) 2.34

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol (2004) 2.32

Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. Can J Cardiol (2007) 2.32

Weekend hospital admission, acute kidney injury, and mortality. J Am Soc Nephrol (2010) 2.30

A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int (2004) 2.29

Access to kidney transplantation among remote- and rural-dwelling patients with kidney failure in the United States. JAMA (2009) 2.26